RARE DISEASE THERAPEUTICS
"RARE DISEASE THERAPEUTICS" is a word mark owned by Rare Disease Therapeutics, Inc., filed at the USPTO on February 26, 2026. It is under examination and covers class 35 (Advertising and Business).
- Status
- Under examination
- Since June 26, 2026
- Filed
- February 26, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 99672556
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns RARE DISEASE THERAPEUTICS
The owner and representative on file with the office.
Owner
Rare Disease Therapeutics, Inc.
Franklin, United States
Representative
Stephanie Scruggs
Bradley Arant Boult Cummings LLP
What the mark covers
The products and services RARE DISEASE THERAPEUTICS is filed for, grouped by Nice class.
Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting and management in the field of clinical trials, namely, providing information management services; Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; Marketing services; Sales promotion services; Market analysis
What has happened so far
Steps recorded by the USPTO, newest first.
- Teas change of correspondence received
- Application extension granted/receipt provided
- Application extension to response period - received
- Notification of non-final action e-mailed
- Non-final action e-mailed
- Non-final action written
- Assigned to examiner
- Assigned to examiner
- Application filing receipt mailed
- New application office supplied data entered
1 earlier step on the official record.
About RARE DISEASE THERAPEUTICS
Who owns the trademark "RARE DISEASE THERAPEUTICS"?
The USPTO trademark "RARE DISEASE THERAPEUTICS" (application 99672556) is owned by Rare Disease Therapeutics, Inc.
What is the status of "RARE DISEASE THERAPEUTICS"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull RARE DISEASE THERAPEUTICS and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2baf-244a-761c-a454-2e339384ebb0
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2baf-244a-761c-a454-2e339384ebb0",
"object": "trademark",
"mark_text": "RARE DISEASE THERAPEUTICS",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "99672556",
"filing_date": "2026-02-26",
"nice_classes": [
35
],
"owners": [
{
"name": "Rare Disease Therapeutics, Inc.",
"entity_id": null
}
]
}